IMC Chicago’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-43,865
Closed -$5.33M 4197
2025
Q3
$4.87M Buy
+43,865
New +$4.99M ﹤0.01% 1579
2025
Q1
Sell
-56,703
Closed -$5.85M 3248
2024
Q4
$5.24M Buy
+56,703
New +$5.11M ﹤0.01% 1202
2024
Q3
Sell
-36,020
Closed -$2.75M 2868
2024
Q2
$2.47M Sell
36,020
-20,705
-37% -$1.38M ﹤0.01% 1441
2024
Q1
$4.16M Sell
56,725
-27,483
-33% -$2.11M ﹤0.01% 1041
2023
Q4
$6.82M Buy
84,208
+27,463
+48% +$2.14M ﹤0.01% 775
2023
Q3
$4.25M Sell
56,745
-1,447
-2% -$111K ﹤0.01% 778
2023
Q2
$4.48M Buy
+58,192
New +$4.64M ﹤0.01% 697
2023
Q1
Sell
-250,858
Closed -$20.8M 1308
2022
Q4
$21.5M Buy
+250,858
New +$19.9M 0.03% 292
2022
Q2
Sell
-66,666
Closed -$4.13M 1092
2022
Q1
$3.96M Buy
+66,666
New +$4.26M ﹤0.01% 604
2021
Q3
Sell
-17,768
Closed -$1.25M 1215
2021
Q2
$1.22M Buy
+17,768
New +$1.19M ﹤0.01% 868
2020
Q2
Sell
-147,473
Closed -$11.3M 920
2020
Q1
$11M Buy
147,473
+86,254
+141% +$5.96M 0.02% 202
2019
Q4
$3.98M Buy
+61,219
New +$3.99M 0.01% 382

Other funds holding GILD

IMC Chicago's GILD Position: Q4 2025 in Review

IMC Chicago sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 43,865 shares — an estimated $5.33M sold.

IMC Chicago first reported a position in GILD in Q4 2019 and held it in 12 quarters. The position peaked at $21.5M in Q4 2022. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • IMC Chicago reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • IMC Chicago sold 43,865 Gilead Sciences shares in Q4 2025, an estimated $5.33M.
  • IMC Chicago first reported a position in Gilead Sciences in Q4 2019 and held it in 12 quarters.
  • IMC Chicago's Gilead Sciences position peaked at $21.5M in Q4 2022.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.